Release from the VA FSS regarding DAPA
MassMods are to be released for changes that take place April 1, 2015 on VA Schedule contracts per the VA Federal Supply Schedule (FSS) Service. This change affects sales reporting if your firm has a DAPA with the Department of Defense, but the MassMod is for all affected Schedule contracts. For further information or assistance on contract compliance, please contact Government Development Center (GDC) at info@GovDevCtr.com or 888-232-3650.
March 2015 Newsletter — Special Edition (direct excerpt from email received from VA Federal Supply Schedule (FSS) Service)
NOTICE OF CHANGE TO CLAUSE 552.238-74 – REGARDING DISTRIBUTION AND PRICING AGREEMENTS (DAPA)
Clause 552.238-74, Industrial Funding Fee and Sales Reporting requires that FSS contractors submit, quarterly, the dollar value (in U.S. dollars and rounded to the nearest whole dollar) of all sales under the contract during the preceding 3-month period, to include any partial month. This process is currently completed on-line through the VA Sales Reporting System.
One of the questions we most often receive is “I have a DAPA, do I need to report those sales on my quarterly sales report?” If your firm has a DAPA with the Department of Defense, you will be required to submit IFF under the VA FSS Contract for all 65IB and Service Schedule (621 I, 621 II and 66 III) sales. If your firm has a DAPA with the Department of Defense for any Non-65IB or Service Schedule requirements, you will not report the DAPA sales against your FSS contract unless an order is issued against a VA FSS Contract Number starting with V797P or V797D. Additionally, FSS inclusive sales will apply to all direct and any eligible Agency Prime Vendor sales. For Prime Vendor sales the contract number will be cited in the related chargeback transaction.
Additionally, all sales issued against a FSS contract starting with V797P or V797D to agencies other than the VA, state & local governments, and direct-to-patient distribution must be reported. Direct all FSS sales reporting & IFF remittance questions to the VA Sales Desk (or contact us at Government Development Center at info@GovDevCtr.com or 888-232-3650.)
MODIFICATION TO INCORPORATE NEW CLAUSE
To allow for updated clauses to be incorporated into current FSS contracts, service schedule specific modifications are employed. These bilateral mass modifications will be issued by the VA Federal Supply Schedule Service to effectuate the newly tailored Industrial Funding Fee and Sales Reporting Clause 552-238-74 by March 31, 2015. The clause will have an effective date of April 01, 2015 at which time vendors under the below mentioned schedules will no longer report DAPA sales and will only report VA FSS sales for contracts starting with V797P or V797D and will apply to all direct and any eligible Agency Prime Vendor sales.
Issued modifications require immediate attention and shall be completed and submitted to the FSS Helpdesk with the subject line “RFM-Contract #-Schedule #- Mass Modification IFF” no later than April 30, 2015. Please see the VA FSS webpage for specific instructions on completing the modification document http://www.va.gov/oal/business/fss/massMods.asp.
Failure to submit the required document(s) by the above mentioned deadline to our office may result in potential contract cancellation.
Schedules reflecting the new tailored clause include:
– 65IIA – Medical Equipment and Supplies – Mass Modification are required
– 65IIF – Patient Mobility Devices – Mass Modifications are required
– 65VA – X-Ray Equipment and Supplies – Mass Modifications are required
– 65IIC – Dental Equipment and Supplies – Mass Modifications are required
– 65VII – Invitro Diagnostics, Reagents, Test Kits & Test Sets – Mass Modifications are required
The following Schedules remain unchanged:
– 65IB – Drugs, Pharmaceuticals & Hematology Related Products -Mass Modifications are not required
– 621 I – Professional & Allied Healthcare Staffing Services – Mass Modifications are not required
– 621 II – Medical Laboratory Testing & Analysis Services – Mass Modifications are not required
– 66 III – Cost Per Test Clinical Laboratory Analyzers – Mass Modifications are not required